| 注册
首页|期刊导航|中国药业|贵州省药品生产企业计算机化系统及电子数据管理相关缺陷分析与对策研究

贵州省药品生产企业计算机化系统及电子数据管理相关缺陷分析与对策研究

郭祺瑞 徐剑 张永萍

中国药业2025,Vol.34Issue(22):7-11,5.
中国药业2025,Vol.34Issue(22):7-11,5.DOI:10.3969/j.issn.1006-4931.2025.22.002

贵州省药品生产企业计算机化系统及电子数据管理相关缺陷分析与对策研究

Analysis on Defects and Countermeasures Related to Computerized Systems and Electronic Data Management in Pharmaceutical Manufacturing Enterprises of Guizhou Province

郭祺瑞 1徐剑 2张永萍2

作者信息

  • 1. 贵州省药品监督管理局检查中心,贵州 贵阳 550081
  • 2. 贵州中医药大学药学院,贵州 贵阳 550004||国家苗药工程技术研究中心,贵州 贵阳 550004
  • 折叠

摘要

Abstract

Objective To analyze the defects related to computerized systems and electronic data management in pharmaceutical manufacturing enterprises,and to study countermeasures.Methods Based on domestic and foreign regulatory requirements and industry status,defects in computerized systems and electronic data management found in Good Manufacturing Practice(GMP)inspections of pharmaceutical manufacturing enterprises by domestic and foreign regulatory authorities in recent years were reviewed,and their characteristics and risks were summarized.Systematic improvement suggestions were put forward according to typical problems found in on-site GMP inspections in Guizhou Province.Results The informatization level of pharmaceutical manufacturing enterprises in Guizhou Province showed a polarized status.The main defects included insufficient validation and verification of computerized systems,incomplete data,unclear responsibilities for access control and privilege management,absence of change control procedures,weak supplier management,absence of audit trail functions,unscientific data backup management,incompatible system interfaces,and untimely system updates.It is suggested to establish a verification strategy covering the entire life cycle of the system,clarify data integrity requirements,implement the ″one person,one account″ and ″least privilege principle″ in account management,incorporate all changes to computerized systems into the quality management system,sign quality agreements with suppliers to clarify compliance responsibilities,regularly test data backup and recovery procedures,conduct special verification on data transmission interfaces among different systems,and perform gap analysis on old systems.Conclusion Pharmaceutical manufacturing enterprises should build a ″compliance-intelligence-safety″ trinity management system,and continuously improve the compliance level of computerized system application in accordance with industry laws and regulations,national policy trends and the current status of informatization promotion.

关键词

药品生产企业/计算机化系统/电子数据管理/《药品生产质量管理规范》

Key words

pharmaceutical manufacturing enterprise/computerized system/electronic data management/Good Manufacturing Practice

分类

医药卫生

引用本文复制引用

郭祺瑞,徐剑,张永萍..贵州省药品生产企业计算机化系统及电子数据管理相关缺陷分析与对策研究[J].中国药业,2025,34(22):7-11,5.

基金项目

贵州省高层次创新型人才项目[黔科合平台人才-GCC[2023]037] ()

贵州省科技计划项目[黔科合中引地[2023]006]. ()

中国药业

1006-4931

访问量1
|
下载量0
段落导航相关论文